| (19) |
 |
|
(11) |
EP 4 397 249 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
21.08.2024 Bulletin 2024/34 |
| (43) |
Date of publication A2: |
|
10.07.2024 Bulletin 2024/28 |
| (22) |
Date of filing: 05.12.2014 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
23.12.2013 US 201361920207 P
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
21163623.8 / 3858254 |
|
14824199.5 / 3086716 |
| (71) |
Applicant: Teleflex Life Sciences LLC |
|
Wilmington, DE 19808 (US) |
|
| (72) |
Inventors: |
|
- WALTERS, Greg A
Exton, PA 19341 (US)
- GRINTZ, Joseph Todd
Glenmoore, PA 19343 (US)
|
| (74) |
Representative: Haseltine Lake Kempner LLP |
|
One Portwall Square
Portwall Lane
Bristol BS1 6BH
Bristol BS1 6BH (GB) |
|
| |
|
| (54) |
VASCULAR CLOSURE DEVICE |
(57) A vascular closure device configured to seal a puncture site in the vessel wall in
a more efficient manner is disclosed.